These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28270366)

  • 1. Immune defects caused by mutations in the ubiquitin system.
    Etzioni A; Ciechanover A; Pikarsky E
    J Allergy Clin Immunol; 2017 Mar; 139(3):743-753. PubMed ID: 28270366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear ubiquitination-mediated NF-κB regulation and its related disorders.
    Tokunaga F
    J Biochem; 2013 Oct; 154(4):313-23. PubMed ID: 23969028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation.
    Schnappauf O; Aksentijevich I
    J Leukoc Biol; 2020 Aug; 108(2):573-589. PubMed ID: 32678922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
    Klein T; Fung SY; Renner F; Blank MA; Dufour A; Kang S; Bolger-Munro M; Scurll JM; Priatel JJ; Schweigler P; Melkko S; Gold MR; Viner RI; Régnier CH; Turvey SE; Overall CM
    Nat Commun; 2015 Nov; 6():8777. PubMed ID: 26525107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
    Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
    Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency.
    McDonald DR; Mooster JL; Reddy M; Bawle E; Secord E; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):900-7. PubMed ID: 17931563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination.
    Elton L; Carpentier I; Verhelst K; Staal J; Beyaert R
    Immunol Rev; 2015 Jul; 266(1):208-21. PubMed ID: 26085217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signaling.
    Paciolla M; Pescatore A; Conte MI; Esposito E; Incoronato M; Lioi MB; Fusco F; Ursini MV
    Genes Immun; 2015 Jun; 16(4):239-46. PubMed ID: 25764117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases.
    Aksentijevich I; Zhou Q
    Front Immunol; 2017; 8():399. PubMed ID: 28469620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease.
    Beck DB; Aksentijevich I
    Front Immunol; 2019; 10():101. PubMed ID: 30766537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin system in immune regulation.
    Park Y; Jin HS; Aki D; Lee J; Liu YC
    Adv Immunol; 2014; 124():17-66. PubMed ID: 25175772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
    Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation.
    Orange JS; Levy O; Geha RS
    Immunol Rev; 2005 Feb; 203():21-37. PubMed ID: 15661019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ubiquitin-binding domains in human pathophysiology.
    Sokratous K; Hadjisavvas A; Diamandis EP; Kyriacou K
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):280-90. PubMed ID: 24901807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.
    Orange JS; Jain A; Ballas ZK; Schneider LC; Geha RS; Bonilla FA
    J Allergy Clin Immunol; 2004 Apr; 113(4):725-33. PubMed ID: 15100680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor κB signaling.
    Alexia C; Poalas K; Carvalho G; Zemirli N; Dwyer J; Dubois SM; Hatchi EM; Cordeiro N; Smith SS; Castanier C; Le Guelte A; Wan L; Kang Y; Vazquez A; Gavard J; Arnoult D; Bidère N
    Sci Signal; 2013 Sep; 6(291):ra79. PubMed ID: 24003256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse roles of the ubiquitin system in NF-κB activation.
    Iwai K
    Biochim Biophys Acta; 2014 Jan; 1843(1):129-36. PubMed ID: 23523932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM family proteins: emerging class of RING E3 ligases as regulator of NF-κB pathway.
    Tomar D; Singh R
    Biol Cell; 2015 Jan; 107(1):22-40. PubMed ID: 25319221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.